Literature DB >> 17482228

Cytotoxic, thrombolytic and edematogenic activities of leucurolysin-a, a metalloproteinase from Bothrops leucurus snake venom.

L H Gremski1, O M Chaim, K S Paludo, Y B Sade, M F Otuki, M Richardson, W Gremski, E F Sanchez, S S Veiga.   

Abstract

Leucurolysin-a (leuc-a), a 23 kDa non-hemorrhagic metalloproteinase, is found in venom of the viper Bothrops leucurus. Here, we examine the biological consequences of leuc-a, including thrombolytic activity, direct effects on endothelial cells in culture and edematogenic activity in vivo. We demonstrate fibrinolytic activity of leuc-a, in which the protease specifically degrades alpha, beta, and gamma-gamma chains. While not causing hemorrhaging, leuc-a does cause thrombolytic activities in whole blood clots. Endothelial cells are highly resistant to leuc-a in culture. Cell viability suffered only when cells were exposed to large quantities of the protease. Nevertheless, leuc-a induces changes in cell morphology. The impact of leuc-a on cell adhesion was confirmed by an adhesion assay, in which cell adhesion to fibronectin decreased due to leuc-a. This mild cellular impact is unlike that of crude venom, where lower concentrations triggered cell death and a greater reduction in cell adhesion. Also, leuc-a increased microvessel permeability with marked edema in mice peritoneum and foot pads. These effects are similar to those of other P-I class SVPMs. These in vivo effects were weaker when crude venom was tested. In conclusion, albeit not showing significant hemorrhagic activity, leuc-a can induce a prominent edema which appears to be significant in the local effects observed after B. leucurus venom accidents.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17482228     DOI: 10.1016/j.toxicon.2007.03.002

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  6 in total

1.  Purification and characterization of a metalloproteinase, Porthidin-1, from the venom of Lansberg's hog-nosed pitvipers (Porthidium lansbergii hutmanni).

Authors:  María E Girón; Amalid Estrella; Elda E Sánchez; Jacob Galán; W Andy Tao; Belsy Guerrero; Ana M Salazar; Alexis Rodríguez-Acosta
Journal:  Toxicon       Date:  2011-01-19       Impact factor: 3.033

2.  Pharmaco-modulations of induced edema and vascular permeability changes by Vipera lebetina venom: inflammatory mechanisms.

Authors:  Fatima Sebia-Amrane; Fatima Laraba-Djebari
Journal:  Inflammation       Date:  2013-04       Impact factor: 4.092

3.  Effect of photobiomodulation on endothelial cell exposed to Bothrops jararaca venom.

Authors:  Ana Tereza Barufi Franco; Luciana Miato Gonçalves Silva; Marcília Silva Costa; Silvia Fernanda Zamuner; Rodolfo Paula Vieira; Catarina de Fatima Pereira Teixeira; Stella Regina Zamuner
Journal:  Lasers Med Sci       Date:  2016-05-04       Impact factor: 3.161

4.  Cytotoxic Effect of Iranian Vipera lebetina Snake Venom on HUVEC Cells.

Authors:  Maryam Kakanj; Mahmoud Ghazi-Khansari; Abbas Zare Mirakabadi; Bahram Daraei; Hossein Vatanpour
Journal:  Iran J Pharm Res       Date:  2015       Impact factor: 1.696

5.  Purification procedure for the isolation of a P-I metalloprotease and an acidic phospholipase A2 from Bothrops atrox snake venom.

Authors:  Danilo L Menaldo; Anna L Jacob-Ferreira; Carolina P Bernardes; Adélia C O Cintra; Suely V Sampaio
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2015-08-13

6.  Abarema cochliacarpos extract decreases the inflammatory process and skeletal muscle injury induced by Bothrops leucurus venom.

Authors:  Jeison Saturnino-Oliveira; Daiana Do Carmo Santos; Adriana Gibara Guimarães; Antônio Santos Dias; Marcelo Amorim Tomaz; Marcos Monteiro-Machado; Charles Santos Estevam; Waldecy De Lucca Júnior; Durvanei Augusto Maria; Paulo A Melo; Adriano Antunes de Souza Araújo; Márcio Roberto Viana Santos; Jackson Roberto Guedes da Silva Almeida; Rita de Cássia Meneses Oliveira; Aldeidia Pereira de Oliveira; Lucindo José Quintans Júnior
Journal:  Biomed Res Int       Date:  2014-07-20       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.